RHOA and endothelial dysfunction: Studies with specific RhoA/Rho kinase inhibitors have shown multiple benefits, for example in the control of blood pressure, decreased cardiac damage in ischemia/reperfusion models, an enhanced vascular antioxidant response and normalization of vascular parameters and NO production in a mouse model of age‐induced endothelial dysfunction.118, 119, 120, 121, 122, 123